Analysed MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) News Sources
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
19-04-2026
yahoo.com
Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting
14-04-2026
yahoo.com
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
23-03-2026
yahoo.com
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
19-03-2026
yahoo.com
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
26-02-2026
yahoo.com
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
26-02-2026
yahoo.com
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready
02-02-2026
marketbeat.com
What is the current price of MOLECULAR PARTNERS AG (MLLCF:OTCMKTS)?
The current price of MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) is $2.5.
MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) since the previous trading day is $0.17.
MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) since the previous trading day is 7.2961%.
What is the most recent average sentiment score for MOLECULAR PARTNERS AG (MLLCF:OTCMKTS)?
The most recent average sentiment score for MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for MOLECULAR PARTNERS AG (MLLCF:OTCMKTS)?
The most recent sentiment for MOLECULAR PARTNERS AG (MLLCF:OTCMKTS) is .
SEC-8K** Filing Available For MOLECULAR PARTNERS AG (MLLCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.